Nucleic acid sample quality control (QC) refers to the processes and technologies used to assess the purity, concentration, and integrity of DNA and RNA samples prior to downstream applications such as sequencing, PCR, and molecular diagnostics. These processes are essential to ensure reliable, reproducible, and accurate results across research and clinical workflows.
With the increasing use of advanced molecular techniques such as next-generation sequencing (NGS), qPCR, and transcriptomics, the importance of sample quality has grown significantly. High-quality nucleic acid inputs improve analytical precision, reduce experimental errors, and enhance overall workflow efficiency.
According to BIS Research, the global nucleic acid sample QC market was valued at $267.2 million in 2024 and is projected to reach $483.9 million by 2035, growing at a CAGR of 5.66% from 2025 to 2035, highlighting its growing importance in genomics and molecular biology workflows.
Download the complete TOC and Request Sample Report
Key Drivers:
• Growing adoption of next-generation sequencing and PCR-based technologies
• Rising investments in genomics research and precision medicine
• Increasing demand for accurate and reproducible laboratory workflows
• Expansion of biopharmaceutical R&D and drug discovery pipelines
• Shift toward automation and high-throughput laboratory environments
According to Principal Analyst at BIS Research:
“The nucleic acid sample QC market is expected to grow steadily as laboratories increasingly prioritize data accuracy, workflow standardization, and reproducibility. The expansion of sequencing technologies and molecular diagnostics is accelerating the need for fast, automated, and reliable QC solutions. As precision medicine and genomics adoption rise globally, nucleic acid quality control will remain a critical enabler of successful laboratory outcomes.”
What is the expected growth outlook?
The market is expected to grow at a CAGR of 5.66% from 2025 to 2035, reaching approximately $483.9 million by 2035.
Who are the key leaders in this market?
Major players include Agilent Technologies, Thermo Fisher Scientific, QIAGEN, Bio-Rad Laboratories, Danaher Corporation, Revvity, Promega Corporation, and Eppendorf SE, along with emerging companies such as DeNovix and Implen.
Which segment dominates the market?
Consumables and reagents lead the market due to recurring usage, while spectrophotometry remains the most widely adopted technology segment.
Want to Make Data-Backed Moves in the Life Sciences Market?
BIS Research provides expert-driven insights, detailed market segmentation, and strategic advisory across healthcare, biotechnology, and advanced diagnostics domains.
Request a sample report
Book a Preview
Download the complete TOC
